823 related articles for article (PubMed ID: 26304901)
21. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
Moroz V; Machin D; Faldum A; Hero B; Iehara T; Mosseri V; Ladenstein R; De Bernardi B; Rubie H; Berthold F; Matthay KK; Monclair T; Ambros PF; Pearson AD; Cohn SL; London WB
Eur J Cancer; 2011 Mar; 47(4):561-71. PubMed ID: 21112770
[TBL] [Abstract][Full Text] [Related]
22. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Hematol Oncol Clin North Am; 2010 Feb; 24(1):65-86. PubMed ID: 20113896
[TBL] [Abstract][Full Text] [Related]
23. Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research.
Øra I; Eggert A
Semin Cancer Biol; 2011 Oct; 21(4):217-28. PubMed ID: 21798350
[TBL] [Abstract][Full Text] [Related]
24. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
25. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
26. Genetic discoveries and treatment advances in neuroblastoma.
Bagatell R; Cohn SL
Curr Opin Pediatr; 2016 Feb; 28(1):19-25. PubMed ID: 26576010
[TBL] [Abstract][Full Text] [Related]
27. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
Owens C; Irwin M
Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
[TBL] [Abstract][Full Text] [Related]
28. Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future.
Liang WH; Federico SM; London WB; Naranjo A; Irwin MS; Volchenboum SL; Cohn SL
JCO Clin Cancer Inform; 2020 Oct; 4():895-905. PubMed ID: 33058692
[TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.
Mossé YP; Deyell RJ; Berthold F; Nagakawara A; Ambros PF; Monclair T; Cohn SL; Pearson AD; London WB; Matthay KK
Pediatr Blood Cancer; 2014 Apr; 61(4):627-35. PubMed ID: 24038992
[TBL] [Abstract][Full Text] [Related]
30. Advances in the diagnosis and treatment of neuroblastoma.
Weinstein JL; Katzenstein HM; Cohn SL
Oncologist; 2003; 8(3):278-92. PubMed ID: 12773750
[TBL] [Abstract][Full Text] [Related]
31. Neuroblastoma: experience from National University Health System, Singapore (1987-2008).
Tan C; Sabai SM; Tin AS; Quah TC; Aung L
Singapore Med J; 2012 Jan; 53(1):19-25. PubMed ID: 22252178
[TBL] [Abstract][Full Text] [Related]
32. Neuroblastoma in Turkish children: experience of a single center.
Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
[TBL] [Abstract][Full Text] [Related]
33. Current aspects of biology, risk assessment, and treatment of neuroblastoma.
Haase GM; Perez C; Atkinson JB
Semin Surg Oncol; 1999 Mar; 16(2):91-104. PubMed ID: 9988866
[TBL] [Abstract][Full Text] [Related]
34. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.
Pollack IF
J Neurosurg Pediatr; 2011 Aug; 8(2):135-48. PubMed ID: 21806354
[TBL] [Abstract][Full Text] [Related]
35. [Results of the Competence Net Pediatric Oncology and Haematology--a view back].
Creutzig U; Herold R; Henze G
Klin Padiatr; 2010 Nov; 222(6):333-6. PubMed ID: 21058219
[No Abstract] [Full Text] [Related]
36. Identification of therapy-sensitive and therapy-resistant neuroblastoma subtypes in stages III, IVs and IV.
Kyo Y; Tanaka T; Hayashi K; Iehara T; Kaneko M; Hosoi H; Sugimoto T; Hamasaki M; Kobayashi M; Sawada T
Cancer Lett; 2011 Jul; 306(1):27-33. PubMed ID: 21486686
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of gene expression-based classification for neuroblastoma.
Oberthuer A; Hero B; Berthold F; Juraeva D; Faldum A; Kahlert Y; Asgharzadeh S; Seeger R; Scaruffi P; Tonini GP; Janoueix-Lerosey I; Delattre O; Schleiermacher G; Vandesompele J; Vermeulen J; Speleman F; Noguera R; Piqueras M; Bénard J; Valent A; Avigad S; Yaniv I; Weber A; Christiansen H; Grundy RG; Schardt K; Schwab M; Eils R; Warnat P; Kaderali L; Simon T; Decarolis B; Theissen J; Westermann F; Brors B; Fischer M
J Clin Oncol; 2010 Jul; 28(21):3506-15. PubMed ID: 20567016
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.
Bagatell R; McHugh K; Naranjo A; Van Ryn C; Kirby C; Brock P; Lyons KA; States LJ; Rojas Y; Miller A; Volchenboum SL; Simon T; Krug B; Sarnacki S; Valteau-Couanet D; von Schweinitz D; Kammer B; Granata C; Pio L; Park JR; Nuchtern J
J Clin Oncol; 2016 Mar; 34(7):740-6. PubMed ID: 26755515
[TBL] [Abstract][Full Text] [Related]
39. The promotion of resilience: the new paradigm in paediatric oncology.
Masera G; Cesa Bianchi M; Delle Fave A
Epidemiol Prev; 2013; 37(1 Suppl 1):278-81. PubMed ID: 23585452
[No Abstract] [Full Text] [Related]
40. Ten challenges in the management of neuroblastoma.
Gains J; Mandeville H; Cork N; Brock P; Gaze M
Future Oncol; 2012 Jul; 8(7):839-58. PubMed ID: 22830404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
